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Background: Patients with both hypoplastic left heart syndrome (HLHS) and Turner Syndrome (TS) have high rates of mortality. However, 
little is known about their long-term survival or causes of death.
methods:  The Texas Birth Defect Registry was queried for all cases of HLHS with TS born during 1999-2007. Detailed birth, diagnostic, 
and survival data were obtained. Patients with HLHS with TS (TS+/HLHS) were compared to patients who had HLHS without other 
extracardiac birth defects or genetic disorders (TS-/HLHS). We used Kaplan-Meier and Cox Regression analyses to compare survival.
results:  Of 542 patients with HLHS, 11 had TS, 71 had other extracardiac birth defects or genetic disorders (ECBD), and 463 had no 
other ECBD. Comparing those with TS+/HLHS to TS-/HLHS, 100% vs 35% were female (p<0.001), median birth weight was 2140 g 
(IQR 1780-2730) vs 3196 g (IQR 2807-3540, p<0.001), and median gestational age was 35 weeks (IQR 34-38) vs 39 weeks (IQR 38-39, 
p=0.001). There were no differences between the groups based on birth year, distance between birth hospital and surgical center, prenatal 
diagnosis or surgical center volume. Neonatal mortality in the TS+ group compared to the TS- group was 36% vs 27% (log rank=0.30) and 
infant mortality was 89% vs 51% (log rank=0.001). Ten of 11 TS+ patients died during the study period (91%). Six patients died prior to 
any surgery, 5 underwent Norwood, 3 died after Norwood, and 2 survived past Glenn. One post-Glenn patient was not known to have died 
by the end of the study period (1.4 years), and the oldest post-Glenn patient died at 1.7 years. In multivariable analysis, when controlling 
for preterm delivery (<37 weeks) and low birth weight (<2500 g), TS remained associated with earlier death (HR 1.99, 95% CI: 1.02-3.87). 
The underlying cause of death was listed as the patient’s congenital heart disease on all the death certificates; one patient had respiratory 
arrest after a procedural complication and one died of a dysrhythmia.
Conclusion:  TS in the presence of HLHS is associated with significant mortality, and continues to be when accounting for the lower birth 
weight and gestational age in these infants.
